Sfoglia per AUTORE
WITZIG TE
Collezione AOU Città della Salute di Torino

  

Items : 8

2022
AOU Città della Salute di Torino

Hagner P; Li Y; Sangha R; Shen F; Greenwald DR; Klein LM; Isufi I; Andorsky DJ; Corradini P; Kenkre VP; Boccomini C; Flinn IW; Santoro A; Witzig TE; Bijou F; Chavez JC; Kuruvilla J; Nastoupil LJ; Dobmeyer J; Gong N; Uttamsingh S; Pourdehnad M; Ribrag V;

2021
AOU Città della Salute di Torino

Villarraga HR; Habermann TM; Nowakowski GS; Witzig TE; Allmer C; Maurer MJ; Thanarajasingam G; Inwards DJ; Herrmann J; Castellino A; Larson MC; Boddicker NJ; Slager SL; Cerhan JR; Thompson CA;

ROBUST: A Phase III Study of Lenalidomide Plus R-CHOP Versus Placebo Plus R-CHOP in Previously Untreated Patients With ABC-Type Diffuse Large B-Cell Lymphoma. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2021 Apr 20;39(12):1317-1328. doi: 10.1200/JCO.20.01366. Epub 2021 Feb 23.
2021
AOU Città della Salute di Torino

Hersey S; Czuczman M; Kato K; Izutsu K; Yamamoto K; Tani M; Cavallo F; Yoon DH; Molinari AL; Mócikova H; Piazza F; Bergua JM; Belada D; Jin J; Hong X; Zhu J; Özcan M; Jurczak W; Zhang Q; Scott DW; Gascoyne RD; Nowakowski GS; Chiappella A; Kilcoyne A; Russo J; Hudak K; Zhang J; Wade S; Witzig TE; et alii...

Persistent mediastinal FDG uptake on PET-CT after frontline therapy for Hodgkin lymphoma: biopsy, treat or observe? in Leukemia & lymphoma / Leuk Lymphoma. 2020 Feb;61(2):318-327. doi: 10.1080/10428194.2019.1663422. Epub 2019 Sep 26.
2020
AOU Città della Salute di Torino

Vitolo U; Young JR; Ristow KM; Botto B; Inwards DJ; Johnston PB; Micallef IN; Witzig TE; Habermann TM; Novo M; Nowakowski GS; Ansell SM;

Variable global distribution of cell-of-origin from the ROBUST phase III study in diffuse large B-cell lymphoma. in Haematologica / Haematologica. 2020 Jan 31;105(2):e72-e75. doi: 10.3324/haematol.2019.220475. Print 2020.
2020
AOU Città della Salute di Torino

Nowakowski GS; Chiappella A; Witzig TE; Scott DW; Spina M; Gascoyne RD; Zhang L; Russo J; Kang J; Zhang J; Xu Y; Vitolo U;

2018
AOU Città della Salute di Torino

Castellino A; Chiappella A; LaPlant BR; Pederson LD; Gaidano G; Macon WR; Inghirami G; Reeder CB; Tucci A; King RL; Congiu A; Foran JM; Pavone V; Rivera CE; Spina M; Ansell SM; Cavallo F; Molinari AL; Ciccone G; Habermann TM; Witzig TE; Vitolo U; Nowakowski GS; Castellino A; Chiappella A; LaPlant BR; Pederson LD; Gaidano G; Macon WR; et alii...

ROBUST: Lenalidomide-R-CHOP versus placebo-R-CHOP in previously untreated ABC-type diffuse large B-cell lymphoma. in Future oncology (London, England) / Future Oncol. 2016 Jul;12(13):1553-63. doi: 10.2217/fon-2016-0130. Epub 2016 Apr 18.
2016
AOU Città della Salute di Torino

Nowakowski GS; Chiappella A; Witzig TE; Spina M; Gascoyne RD; Zhang L; Flament J; Repici J; Vitolo U; Nowakowski GS; Chiappella A; Witzig TE; Spina M; Gascoyne RD; Zhang L; Flament J; Repici J; Vitolo U;

A comprehensive review of lenalidomide therapy for B-cell non-Hodgkin lymphoma. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2015 Aug;26(8):1667-77. doi: 10.1093/annonc/mdv102. Epub 2015 Feb 23.
2015
AOU Città della Salute di Torino

Witzig TE; Nowakowski GS; Habermann TM; Goy A; Hernandez-Ilizaliturri FJ; Chiappella A; Vitolo U; Fowler N; Czuczman MS;